本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Stoke Therapeutics, Inc.

9.22
+0.61007.08%
盘后8.76-0.4600-4.99%17:43 EDT
成交量:113.72万
成交额:1,030.23万
市值:4.99亿
市盈率:-5.60
高:9.30
开:8.74
低:8.52
收:8.61
数据加载中...
2024/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/21

重要事件披露

Form 8-K - Current report
2024/06/17

SEC问询函

Form CORRESP - Correspondence
2024/06/06

重要事件披露

Form 8-K - Current report
2024/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/30

重要事件披露

Form 8-K - Current report
2024/04/18

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/28

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/03/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]